Main event on health industry Oslo Life Science 2019

The main event of Oslo Life Science 2019 will highlight inspiring examples on collaboration between academia and industry that have benefitted patients and society. How can we learn from these examples while building the health industry in Oslo and Norway?

The event consists of three parts: 1) inspiring examples on collaboration between academia and industry that have benefitted patients and society, 2) the journey from academia to industry with pitches from the new generation of entrepreneurs, and 3) presentation and debate on the new white paper on health industry.

Target groups: researchers, students, bureaucrats, businesspeople, investors and politicians. 

Registration form at the bottom of this page.

Welcome and the latest news on the life science building at UiO

Svein Stølen, Rector, UiO

Opening speech by Bayer – the company that bought Algeta, the number one life science success story of the University of Oslo

Kemal Malik, Board of Management of Bayer AG responsible for innovation

FinnGen – a unique collaboration between academia and industry to find the next breakthroughs in disease prevention, diagnosis and treatment
Aarno Palotie, Research Director, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki; Faculty member, Center for Human Genome Research at the Massachusetts General Hospital; Associate member, Broad Institute of MIT and Harvard

Innovation and industry collaboration in translational research – lessons learned from Finnish FIMM to inspire the Norwegian NCMM and the life science community in Oslo

Janna Saarela, the new Director of the Centre for Molecular Medicine Norway (NCMM), UiO, who comes from Institute for Molecular Medicine Finland (FIMM)

Nt-proBNP – the biomarker for heart failure that conquered the world from Oslo

Professor II Christian Hall, University of Oslo and Vestre Viken Hospital Trust; and Mathias Egermark, MD, Senior Vice President, Life Cycle Leader Cardiac, Women's Health & Personalised Healthcare Solutions, Roche Diagnostics International

Cutting edge technology for the benefit of patients and society from successful collaboration between the intervention centre at Oslo University Hospital and Siemens

Anne Figel, Director Global Marketing Neurosurgery, Trauma and Orthopedics at Siemens Healthineers

The journey from academia to industry – pitches from the new generation of entrepreneurs
Projects in UiO:Life Science's innovation programme for health related life sciences SPARK Norway, Oslo Cancer Cluster and Norway Health Tech. Among others you will meet:

  • Simone Mester, PhD student, UiO/OUS and project leader SPARK Norway
  • Johanna Olweus, Professor, UiO/OUS
  • Claudia Alejandra McDonald Bøen, PhD, CEO, Arctic Pharma AS
  • Projects leaders of new SPARK Norway projects that will be selected by a panel and approved by the UiO:Life Science board in the end of January

The new white paper on health industry

Presented by Bent Høie, Minister of Health
  Debate on lessons learned from the examples we’ve heard – and a new era with the new white paper on health industry
  • Per Morten Sandset, Vice-Rector Research and Innovation, UiO
  • Kathrine Myhre, CEO, Norway Health Tech
  • Ketil Widerberg, General Manager, Oslo Cancer Cluster
  • Monica Larsen, Manager of Research and Development, The Pharmaceutical Industry (LMI)

Closing remarks

Carl Henrik Gørbitz, Director, UiO:Life Science


Published Nov. 19, 2018 4:24 PM - Last modified Jan. 14, 2019 6:04 PM